Benzinga
Benzinga
Benzinga
dimanche, septembre 27

Nutex Health Inc

NUTXNASDAQ
Trade with Public
Trade with Public
$220.11
15.527.59%
À la clôture: Sep 25, 5:00 PM EST
$220.00
-0.11-0.05%
Après les heures: Sep 25, 7:58 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerRapport sur les stocks

Nutex Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Nutex Health (NUTX).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$289Upside to Avg. PT+31.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →
DateFirmAnalystActionRating ChangePrice Target
Sep 25, 2026Freedom Capital MarketsGene MannheimerPT RaiseBuy$280→$306
Sep 4, 2026B. Riley SecuritiesYuan ZhiPT RaiseBuy$290→$325
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306

Freedom Capital Markets analyst Gene Mannheimer maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $280 to $306.
Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

B. Riley Securities analyst Yuan Zhi maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $290 to $325.
Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310

Lake Street analyst Ben Haynor maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $235 to $310.
Benzinga Newsdesk

PRO
B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290

B. Riley Securities analyst Anderson Schock initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $290.
Benzinga Newsdesk

PRO
Lake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235

Lake Street analyst Ben Haynor initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $235.
Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205

Maxim Group analyst Anthony Vendetti maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $225 to $205.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved